What we have learned from the Methadone Maintenance Treatment of Dual Disorder Heroin Use Disorder patients

scientific article published on 03 February 2019

What we have learned from the Methadone Maintenance Treatment of Dual Disorder Heroin Use Disorder patients is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.3390/IJERPH16030447
P932PMC publication ID6388207
P698PubMed publication ID30717435

P50authorAngelo Giovanni Icro MaremmaniQ41340617
P2093author name stringIcro Maremmani
Matteo Pacini
P2860cites workCocaine-induced paranoia and psychosis pronenessQ28334006
Activation of mu opioid receptors in the nucleus raphe dorsalis blocks apomorphine-induced aggression in rats: serotonin appears not to be involvedQ28342706
Disulfiram treatment for cocaine dependence in methadone-maintained opioid addictsQ28373528
Therapeutic Community for Drug Addicts, Long-Term Measurement of Emotional ChangesQ51323367
Methadone and cocaineQ51678560
Lithium treatment for cocaine abusers with bipolar spectrum disorders.Q51736051
Long-term outcomes of treatment-resistant heroin addicts with and without DSM-IV axis I psychiatric comorbidity (dual diagnosis).Q51889746
Alcohol and substance abuse among schizophrenic patients presenting to an emergency psychiatric service.Q52065069
Adolescent depression, alcohol and drug abuse.Q52075726
Effects of post-trial administration of naloxone and beta-endorphin on shock-induced fighting in rats.Q52094404
The significance of alcoholism in treated opiate addicts.Q52098070
Heterogeneity of psychiatric diagnosis in treated opiate addicts.Q52099346
Naloxone and naltrexone in mental illness and tardive dyskinesia.Q52100145
Alcoholism and alcohol dependence in narcotic addicts: a prospective study with a five-year follow-up.Q52102645
A comparison of the SADS/RDC and the DSM-III. Diagnosing drug abusers.Q52105190
Comparison of psychometric measures in psychiatric patients using heroin and other drugsQ52116499
Cannabis-induced psychosis.Q52122546
Chronic psychoses and addiction to morphine.Q52191770
Alcohol use in the opiate use cycle of the heroin addict.Q52264387
Aspects of the psychopathology and pathophysiology of addictionQ52264496
Use of fluoxetine in heroin addictionQ52265295
Pain Tolerance and Narcotic AddictionQ52269738
Adolescent opiate addiction: a study of control and addict subjects.Q52283199
Frequency of Use of Diazepam in Individuals on Probation and in Methadone Maintenance Programs: Clinical NoteQ52703784
Antagonism of cocaine highs by lithiumQ52705367
The use of tranquilizers in the treatment of mixed drug abuseQ52716864
[Benzodiazepines and barbiturates in chronic alcoholics and opiate addicts. An epidemiological study of hospitalized addicts]Q53044895
The long-term outcome of patients with heroin use disorder/dual disorder (chronic psychosis) after admission to enhanced methadone maintenance.Q53402431
Depression, demographic dimensions, and drug abuse.Q53960769
Effect of acute and chronic ethanol treatment on gamma-aminobutyric acid levels and on aminooxyacetic acid-induced GABA accumulationQ54238972
The effectiveness of the combination fluoxetine-naltrexone in bulimia nervosa.Q54413091
Prevalence of substance abuse in schizophrenia: demographic and clinical correlates.Q55056971
Predictors of outcome in treatment of opiate addicts: Evidence for the multidimensional nature of addicts' problemsQ57151178
Defensive behaviors in infant rhesus monkeys: environmental cues and neurochemical regulation.Q51179442
Differential control of aggression by the midbrain.Q51235523
Opiate addiction and depression--cause or effect?Q51243236
DSM-III personality type and dose levels in methadone maintenance patients.Q51264411
Withdrawal reaction from long-term, low-dosage administration of diazepam. A double-blind, placebo-controlled case study.Q51271810
Beta-endorphin--induced changes in schizophrenic and depressed patients.Q51284693
Depression and anxiety in heroin addicts: a placebo-controlled study of doxepin in combination with methadoneQ51299755
Cocaine psychoses: a continuum modelQ51300015
Phoenix House. Changes in psychopathological signs of resident drug addicts.Q51315645
Psychological adjustment--mood and personality fluctuations of long-term methadone maintenance patients.Q51322236
Stimulant psychosis: symptom profile and acute clinical courseQ31416884
Toward a rational pharmacotherapy of comorbid substance abuse in schizophrenic patientsQ33586360
Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomesQ33586386
The effects of clozapine on aggression and substance abuse in schizophrenic patientsQ33662417
Cannabis psychosis and acute schizophrenia. a case-control study from IndiaQ33679657
The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependenceQ34194511
Abuse of amitriptylineQ34270855
Drug interactions of methadone with CNS-active agentsQ34503997
Gammahydroxybutyrate: an endogenous regulator of energy metabolismQ34515877
In vitro interactions between fluoxetine or fluvoxamine and methadone or buprenorphineQ34746998
Significance of gamma-hydroxybutyric acid in the brainQ35660844
Neurobiology of cocaine abuseQ36208834
Differentiation of delta and mu opiate receptor localizations by light microscopic autoradiographyQ36412585
Toward a unitary perspective on the bipolar spectrum and substance abuse: opiate addiction as a paradigmQ36468390
Clozapine. A novel antipsychotic agentQ36485618
The Mechanism of Action of Novel Antipsychotic DrugsQ36515345
Delineating the psychic structure of substance abuse and addictions: should anxiety, mood and impulse-control dysregulation be included?Q37543722
Pharmacological treatment of substance-abusing schizophrenic patientsQ37586675
Antidepressant for substance-abusing schizophrenic patients: a minireviewQ37677771
Mood stabilizers in the treatment of substance use disordersQ37736248
Negative dimension in psychiatry. Amotivational syndrome as a paradigm of negative symptoms in substance abuseQ38084415
Substance abuse and psychosis. The strange case of opioidsQ38190519
Comparison of diazepam and oxazepam: preference, liking and extent of abuse.Q38581234
Interactions between narcotic analgesics and benzodiazepine derivatives on behavior in the mouseQ39118424
Use of psychotropic drugs in treatment of methadone maintained narcotic addictsQ39236556
Psychopathology in substance abusers: diagnosis and treatmentQ39531596
A review of psychoactive substance use and abuse in schizophrenia. Patterns of drug choiceQ39680064
Alcoholism and polydrug abuse in persons on methadone maintenanceQ39787537
Psychotropic Agents in Opiate Addiction: A Brief ReviewQ40082748
Autoradiographic localization of opiate receptors in rat brain. III. The telencephalonQ40097547
Antidepressant treatment in methadone maintenance patientsQ40515803
The relationship between substance abuse and bipolar disorderQ40608577
The Structure of Depression in Heroin Addicts*Q40613475
Lithium: Effects on Subjective Functioning and Morphine-Induced EuphoriaQ40747749
The Effect of Lithium Carbonate on Affect, Mood, and Personality of Normal SubjectsQ40754729
Alprazolam and benzodiazepine dependenceQ40791749
Morphine effects on maternal aggression, pup care and analgesia in miceQ41261192
Alcohol use by heroin addicts: evidence for an inverse relationship. A study of methadone maintenance and drug-free treatment samplesQ41311352
Methadone-disulfiram interaction during methadone maintenanceQ41646891
Substance abuse in schizophrenia: a reviewQ41738239
Pharmacokinetics of gamma-hydroxybutyric acid in alcohol dependent patients after single and repeated oral dosesQ41841648
Adverse interaction between disulfiram and marijuana: a case reportQ42245957
Naltrexone-induced panic attacksQ42544514
Outpatient treatment of 'crack' cocaine smoking with flupenthixol decanoate. A preliminary reportQ42651457
Clonazepam as agonist substitution treatment for benzodiazepine dependence: a case reportQ43248865
Affective temperaments in alcoholic patients.Q43293934
Dual diagnosis and chronology of illness in treatment-seeking Italian patients dependent on heroinQ43543901
Long-term therapy using GHB (sodium gamma hydroxybutyrate) for treatment-resistant chronic alcoholicsQ43689890
Psychotogenic drug use and neuroleptic responseQ43713316
Alcoholism,Heroin Dependency, and Methadone Maintenance: Alternatives and Aids to Conventional Methods of TherapyQ43937810
Clozapine reduces severe self-mutilation and aggression in psychotic patients with borderline personality disorderQ43994379
Overdose, suicide attempts and death among a cohort of naltrexone-treated opioid addictsQ44295286
Alcohol and cocaine use and abuse among opioid addicts engaged in a methadone maintenance treatment programQ44334747
Increasing employment of opioid dependent outpatients: an intensive behavioral interventionQ44348679
Opioid peptides within the midbrain periaqueductal gray suppress affective defense behavior in the cat.Q44348917
Parental alcoholism in opioid addictsQ44350998
A possible opioid receptor dysfunction in some depressive disordersQ44353297
Clozapine reverses cocaine craving in a treatment-resistant mentally ill chemical abuser: a case report and a hypothesisQ44377979
The long-term outcomes of heroin dependent-treatment-resistant patients with bipolar 1 comorbidity after admission to enhanced methadone maintenanceQ44457285
Regional brain acetylcholine levels in rats acutely treated with ethanol or rendered ethanol-dependentQ44489610
Valium use and abuse by methadone maintenance clientsQ44692599
The prevalence of psychiatric disorders in patients with alcohol and other drug problemsQ44905612
Origin of leucine-enkephalin fibers and their two main afferent pathways in the bed nucleus of the stria terminalis in the rat.Q45124017
Severity of psychiatric symptoms as a predictor of benefits from psychotherapy: the Veterans Administration-Penn studyQ45337246
Use of disulfiram for alcoholics in methadone maintenance programs. A Veterans Administration Cooperative StudyQ45337390
[Concomitant lithium and methadone treatment in a bipolar patient: a case report].Q45939235
Doxepin: A Useful Adjunct in the Treatment of Heroin Addicts in a Methadone ProgramQ46659800
Opposed effects of hyperthymic and cyclothymic temperament in substance use disorder (heroin- or alcohol-dependent patients).Q47874724
Naltrexone blocks amphetamine-induced hyperactivity, but not disruption of social and agonistic behavior in mice and squirrel monkeysQ48151370
The pathways mediating affective defense and quiet biting attack behavior from the midbrain central gray of the cat: an autoradiographic studyQ48170187
Regulation of feline aggression by the bed nucleus of stria terminalisQ48381119
High methadone dose significantly reduces cocaine use in methadone maintenance treatment (MMT) patientsQ48709433
Enkephalinergic involvement in periaqueductal gray control of hypothalamically elicited predatory attack in the catQ48718358
Clozapine increases breaking points on a progressive-ratio schedule reinforced by intravenous cocaineQ48833416
Efficacy of gamma-hydroxybutyrate versus placebo in treating narcolepsy-cataplexy: double-blind subjective measuresQ48939710
Induction of 'rage' following microinjections of glutamate into midbrain but not hypothalamus of catsQ48942883
Plasma beta-endorphin concentrations in people with learning disability and self-injurious and/or autistic behaviourQ50303421
Naltrexone in young autistic children: a double-blind, placebo-controlled crossover study.Q50303850
Male and Female Drug Abusers: Social and Psychological Status 2 Years after Treatment in a Therapeutic CommunityQ58293068
Probable metabolic interaction between methadone and fluvoxamine in addict patientsQ59389037
Methadone Maintenance Treatment-A ReplyQ67070205
Delayed psychosis due to L.S.D.Q67239056
The medical safety of the combined usage of disulfiram and methadone. Pharmacological treatment for alcoholic heroin addictsQ67442288
Naloxone-induced modulation of feline aggression elicited from midbrain periaqueductal grayQ68079929
Chronic atypical psychosis associated with MDMA ("ecstasy") abuseQ68323428
The Effect of Prolonged Lithium Ingestion on Morphine Actions in the RatQ68942028
Abusers of alcohol and narcotics: who are they?Q69446856
Alcohol use and abuse: heavy drinking among methadone clientsQ69680988
Medical services provided to 2,394 patients at methadone programs in three statesQ69893042
Early treatment time course of depressive symptoms in opiate addictsQ70124389
Methadone and morphine in depression [proceedings]Q70150186
Imipramine as Treatment for Depression in AddictsQ70254906
Suppression of attack behavior in cats by stimulation of ventral tegmental area and nucleus accumbensQ70645879
Naloxone potentiates shock-induced aggressive behavior in miceQ70668639
A study of SCL-90 scores of 264 methadone patients in treatmentQ70909571
beta-Endorphin. Intravenous infusion causes behavioral change in psychiatric inpatientsQ71231658
Physiological parameters of morphine dependence in man—Tolerance, early abstinence, protracted abstinenceQ71240390
Marihuana psychosis. Acute toxic psychosis associated with the use of Cannabis derivativesQ71356052
Chronic psychosis associated with long-term psychotomimetic drug abuseQ71459143
The peptidergic organization of the cat periaqueductal gray. I. The distribution of immunoreactive enkephalin-containing neurons and terminalsQ71668752
Is treatment for alcoholism effective in persons on methadone maintenance?Q71756632
Effects of opiate antagonists on social and aggressive behavior of isolated miceQ71843340
Clozapine decreases smoking in patients with chronic schizophreniaQ71910827
Methadone dosages and therapeutic compliance during a methadone maintenance programQ72048563
Short-term use of disulfiram with clozapineQ72051246
Haloperidol increases smoking in patients with schizophreniaQ72061658
Reduction of comorbid substance abuse with clozapineQ72248875
Decreased substance use in chronically psychotic patients treated with clozapineQ72382753
Methadone doses and psychopathological symptoms during methadone maintenanceQ72651435
Cocaine Treatment: Research and Clinical Perspectives. Proceedings of a meeting. Bethesda, Maryland, August 16-17, 1990Q72727930
Substance abuse and clozapine treatmentQ72808162
Behavioral and biological effects of acute beta-endorphin injection in schizophrenic and depressed patientsQ72877875
A therapeutic use of the methadone fluvoxamine drug interactionQ73346652
Methadone dose and retention during treatment of heroin addicts with Axis I psychiatric comorbidityQ73788948
[Prevalence of psychiatric disorders in opiate dependent patients in contact with the drug treatment system]Q77140173
Regional distribution of met-enkephalin within the amygdaloid complex and bed nucleus of the stria terminalsQ84235613
Efficacy and safety of sodium oxybate in alcohol-dependent patients with a very high drinking risk levelQ90458983
P275copyright licenseCreative Commons AttributionQ6905323
P6216copyright statuscopyrightedQ50423863
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectpsychosisQ170082
ketoneQ170744
heroin dependenceQ18558272
Psychotic DisordersQ60164659
P304page(s)447
P577publication date2019-02-03
P1433published inInternational Journal of Environmental Research and Public HealthQ6051382
P1476titleWhat we have learned from the Methadone Maintenance Treatment of Dual Disorder Heroin Use Disorder patients
P478volume16

Search more.